Core Scientific, Company Insiders

CORZ Stock  USD 8.51  0.08  0.93%   
Slightly above 65% of Core Scientific,'s corporate insiders are selling. The analysis of insider sentiment suggests that many Core Scientific, Common insiders are, at present, alarmed. Core Scientific, employs about 325 people. The company is managed by 31 executives with a total tenure of roughly 759 years, averaging almost 24.0 years of service per executive, having 10.48 employees per reported executive.

Insider Sentiment 35

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-03-06Jordan LevyAcquired 62500 @ 8.01View
2025-03-03Todd A BeckerDisposed 134250 @ 10.75View
2025-01-24Todd M DucheneDisposed 25277 @ 16.24View
2025-01-22Denise Marie Brucia SterlingDisposed 802 @ 15.64View
2025-01-02Todd M DucheneDisposed 129861 @ 14.24View
2024-11-22Yadin RozovDisposed 105000 @ 18.11View
2024-11-20Todd M DucheneDisposed 25000 @ 17.1View
2024-09-13Jarrod M PattenAcquired 2240 @ 11.05View
2024-09-03Jarrod M PattenAcquired 5021 @ 9.68View
2024-08-30Jarrod M PattenAcquired 1500 @ 9.95View
2024-08-28Jarrod M PattenAcquired 4000 @ 9.7View
2024-08-16Todd M DucheneDisposed 11582 @ 9.41View
2024-06-25Todd M DucheneDisposed 7321 @ 9.39View
2024-06-13Todd M DucheneDisposed 3770 @ 9.99View
Monitoring Core Scientific,'s insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Scientific, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Core Scientific, Management Team Effectiveness

Return On Tangible Assets is likely to drop to -0.86 in 2025. Return On Capital Employed is likely to drop to -0.01 in 2025. At this time, Core Scientific,'s Intangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 851.3 M in 2025, whereas Total Assets are likely to drop slightly above 1.3 B in 2025. Core Scientific,'s management efficiency ratios could be used to measure how well Core Scientific, manages its routine affairs as well as how well it operates its assets and liabilities.
Common Stock Shares Outstanding is likely to drop to about 283.2 M in 2025

Core Scientific, Workforce Comparison

Core Scientific, Common is number one stock in number of employees category among its peers. The total workforce of Information Technology industry is currently estimated at about 142,636. Core Scientific, adds roughly 325 in number of employees claiming only tiny portion of equities under Information Technology industry.

Core Scientific, Profit Margins

The company has Profit Margin (PM) of (2.58) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.42.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.170.2371
Way Down
Pretty Stable

Core Scientific, Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Scientific, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Scientific,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Core Scientific, insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
0.8
8
10
 191,188 
 770,963 
2024-12-01
0.8333
5
6
 874,342 
 809,278 
2024-09-01
4.6667
14
3
 1,830,556 
 115,637 
2024-06-01
4.0
16
4
 4,979,797 
 41,582 
2024-03-01
7.0833
85
12
 166,008,354 
 40,176,374 
2022-09-01
0.75
3
4
 5,000,000 
 41,793 
2022-06-01
0.875
7
8
 10,320,980 
 5,962,536 

Core Scientific, Notable Stakeholders

A Core Scientific, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Core Scientific, often face trade-offs trying to please all of them. Core Scientific,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Core Scientific,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Adam SullivanPresident CEOProfile
Denise SterlingExecutive CFOProfile
Denise CPAExecutive CFOProfile
James NygaardExecutive CFOProfile
James ClevelandChief OfficerProfile
Michael BrosExecutive StrategyProfile
Darin FeinsteinChief CoFounderProfile
Jay BrummettSenior ConstructionProfile
Ian FerreiraChief AIProfile
Russell CannExecutive ServicesProfile
Todd DuCheneChief OfficerProfile
Jeff TaylorSenior OfficerProfile
Jeff PrattSenior PartnershipsProfile
Sean KimbleChief OfficerProfile
Jonathan CharbonneauVice RelationsProfile
Cline KezarHead OperationsProfile
Larry KomChief OfficerProfile
Carol HainesHead PolicyProfile
Rob HeplerHead OperationsProfile
Matt TyndallHead DevelopmentProfile
Allison ReichelVP CommunicationsProfile
Matt BrownChief OfficerProfile
Steven GitlinSenior MarketingProfile
Lynn BurgenerSenior TradeProfile
Michael EsqCoChairman CoFounderProfile
Aaron MccreeryExecutive OperationsProfile
Todd JDChief OfficerProfile
Sangeeta PuriVice OperationsProfile
Kyle BuckettExec OperationsProfile
Sharon OrloppChief OfficerProfile
Scott BrueggemanChief OfficerProfile

About Core Scientific, Management Performance

The success or failure of an entity such as Core Scientific, Common often depends on how effective the management is. Core Scientific, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Core management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Core management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.82)(0.86)
Return On Capital Employed(0.01)(0.01)
Return On Assets(0.82)(0.86)
Return On Equity 1.60  0.92 
Please note, the imprecision that can be found in Core Scientific,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Scientific, Common. Check Core Scientific,'s Beneish M Score to see the likelihood of Core Scientific,'s management manipulating its earnings.

Core Scientific, Workforce Analysis

Traditionally, organizations such as Core Scientific, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Core Scientific, within its industry.

Core Scientific, Manpower Efficiency

Return on Core Scientific, Manpower

Revenue Per Employee1.6M
Revenue Per Executive16.5M
Net Loss Per Employee4M
Net Loss Per Executive42.4M
Working Capital Per Employee2.4M
Working Capital Per Executive24.8M

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.